| Cheplapharm Schweiz GmbH - Tarceva 25 mg, Filmtabletten | | 57266 | | 01 | | Tarceva 25 mg | | Filmtabletten | | L01EB02 | | Erlotinib | | 29.08.2007 | | |
| | Composition | | erlotinibum 25 mg ut erlotinibi hydrochloridum 27.32 mg, lactosum monohydricum 27.43 mg, cellulosum microcristallinum, carboxymethylamylum natricum A et natrii laurilsulfas corresp. natrium 2 mg, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Erlotinib | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 27.43 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 Tablet(s) | | | A | | No |
|
|
